Raise Capital Faster for Your Biotech
Access curated investor lists with verified emails, investment focus, typical check size, and geography. Get in front of the right biotech investor, instantly.

Stop searching. Start pitching.
Handpicked biotech VCs with emails & filters that matter, ready when you are.
Secure Biotech Funding Faster
We deliver curated VC lead lists and investor profiles for life sciences founders raising capital. Access direct contacts (emails) of biotech-focused venture capitalists, filtered by, investment focus (e.g., therapeutics, med tech, digital health), ticket size (250K–10M), and geographic focus. Our data reveals investor priorities past deals, portfolio trends, and funding criteria so you can pitch the right backers, faster.
No more cold outreach. We specialize in biotech fundraising, offering:
- Hyper-targeted VC databases.
- Actionable insights to align your pitch with investor demand.
Stop wasting time on mismatched leads. Close rounds smarter with precision data.
Collapsible content
What makes your database unique?
- Biotech-only focus: No noise from unrelated industries.
- Deep investor profiles: Funding criteria and even which scientific milestones they prioritize.
Why get a biotech-specific database?
- Save 100+ hours: Replace guesswork with a ready-to-pitch list of investors pre-filtered by your stage, therapy area, and capital needs.
- Avoid mismatches: Know which VCs are actively deploying capital in your niche.
- Boost credibility: Use insider data to craft pitches that resonate with investor priorities.
Who uses BioxList?
- Biotech founders raising Seed to Series C rounds.
- Business development teams at life sciences startups.
- Consultants building investor pipelines for clients.
How to use your database?
Receive an Excel file to manually browse and filter investors by stage, investment focus, or ticket size, then export emails from the CSV file for instant outreach to VC decision-makers. No tech skills required.
Your Precision Fundraising Toolkits :
-
2025 US Biotech & Life Sciences Investors List
Regular price €513,63 EURRegular priceUnit price / per -
2025 US Biotech Investor List – Therapeutics Focus + (Their Direct Professional Emails)
Regular price €557,81 EURRegular priceUnit price / per
Blog
View all-
What Is a Biotech Venture Capital?
Uncover the dynamics of Biotech Venture Capital, its role in fueling innovation, and its future prospects. Dive deep into this exciting aspect of biotech industry finance.
What Is a Biotech Venture Capital?
Uncover the dynamics of Biotech Venture Capital, its role in fueling innovation, and its future prospects. Dive deep into this exciting aspect of biotech industry finance.
-
Guide to Biotech Licensing Deals: Structuring a...
Get expert insights into the world of biotech licensing deals! Learn how to structure and negotiate profitable licensing agreements while navigating regulatory challenges in the biotech industry.
Guide to Biotech Licensing Deals: Structuring a...
Get expert insights into the world of biotech licensing deals! Learn how to structure and negotiate profitable licensing agreements while navigating regulatory challenges in the biotech industry.
-
Down Rounds in Biotech: How to Navigate When Ph...
Navigate the challenging landscape of down rounds in biotech with our guide. Learn what to do when Phase 2 trials fail, how to recover, and build resilience.
Down Rounds in Biotech: How to Navigate When Ph...
Navigate the challenging landscape of down rounds in biotech with our guide. Learn what to do when Phase 2 trials fail, how to recover, and build resilience.